Related Experiment Video
Updated: Feb 16, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Neonatal hyperoxia promotes asthma-like features through IL-33-dependent ILC2 responses
In Su Cheon1, Young Min Son1, Li Jiang1
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Ind; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minn.
Neonatal hyperoxia in mice induced asthma-like symptoms. Interleukin-33 (IL-33) and group 2 innate lymphoid cells (ILC2s) were crucial in this process, suggesting therapeutic targets for preventing asthma in preterm infants.
Area of Science:
- Pulmonary medicine
- Immunology
- Neonatal research
Background:
- Premature infants often require oxygen, leading to oxidative stress.
- Oxygen exposure increases the risk of chronic lung disease and asthma in preterm infants.
Purpose of the Study:
- To investigate the mechanisms linking neonatal hyperoxia to asthma development.
- To identify key cellular and molecular pathways involved in hyperoxia-induced asthma.
Main Methods:
- Mice exposed to neonatal hyperoxia and/or house dust mite antigen.
- Assessed airway hyperresponsiveness, inflammation, mucus production, and immune cell responses.
- Measured serum IL-33 and cytokine levels in infants and mice.
Main Results:
- Neonatal hyperoxia caused asthma-like features in mice, including airway inflammation and hyperresponsiveness.
- Elevated IL-33 and ILC2 responses were observed, driven by oxidative stress.
- IL-33 receptor signaling and ILC2s were essential for developing these asthma-like features.
Conclusions:
- An IL-33 and ILC2 axis is critical for neonatal hyperoxia-induced asthma.
- Targeting IL-33, ILC2s, and oxidative stress may prevent or treat asthma in preterm infants.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: